Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: dutton: we are raising our price target to $0.90 per share/B-lunist

Re: dutton: we are raising our price target to $0.90 per share/B-lunist

posted on Dec 11, 2007 04:52PM

YES, PAUL, I AM equally impressed!  Thanks,

T.K.

2
Dec 11, 2007 05:17PM
Share
New Message
Please login to post a reply